Login to Your Account



Other News To Note


Friday, December 16, 2011
• Dicerna Pharmaceuticals Inc., of Watertown, Mass., said partner Kyowa Hakko Kirin Co. Ltd., of Tokyo, elected to advance the first collaborative oncology candidate from research stage into formal development studies, triggering a $5 million milestone payment. In addition, Kyowa exercised an option to bring a second cancer target into the collaboration.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription